Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Authors: Borghaei, H.1 hossein.borghaei@fccc.edu, Paz-Ares, L.2, Horn, L.3,4, Spigel, D. R.5, Steins, M.6, Ready, N. E.7, Chow, L. Q.8, Vokes, E. E.9, Felip, E.10,11, Holgado, E.12, Barlesi, F.13, Kohlhäufl, M.14, Arrieta, O.15, Burgio, M. A.16, Fayette, J.17, Lena, H.18, Poddubskaya, E.19, Gerber, D. E.20, Gettinger, S. N.21, Rudin, C. M.22
Source: New England Journal of Medicine. 10/22/2015, Vol. 373 Issue 17, p1627-1639. 13p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa1507643